Metabotropic neurosteroid/σ-receptor involved in stimulation of nociceptor endings of mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 2, 2001, Pages 703-710

  Ueda, Hiroshi ^a   Inoue, Makoto ^a   Yoshida, Akira ^a   Mizuno, Kiyonobu ^a   Yamamoto, Hideko ^b   Maruo, Junko ^c   Matsuno, Kiyoshi ^c   Mita, Shiro ^c  

^a NAGASAKI UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3,4 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; 3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 3 (HYDROXYPHENYL) N (1 PROPYL)PIPERIDINE; ANTISENSE OLIGODEOXYNUCLEOTIDE; BD 1063; DIPHENHYDRAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTAMINE; METABOTROPIC RECEPTOR AGONIST; NEUROSTEROID; OPIATE AGONIST; PENTAZOCINE; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PRASTERONE SULFATE; PREGNENOLONE SULFATE; PROGESTERONE; SIGMA OPIATE RECEPTOR; SUBSTANCE P; THAPSIGARGIN; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FLEXOR REFLEX; IMMUNOBLOTTING; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SPINAL GANGLION;

ANIMALS; DEHYDROEPIANDROSTERONE SULFATE; DIPHENHYDRAMINE; GANGLIA, SPINAL; HISTAMINE H1 ANTAGONISTS; IMMUNOBLOTTING; MALE; MICE; NARCOTIC ANTAGONISTS; NERVE ENDINGS; NEUROTRANSMITTER AGENTS; NOCICEPTORS; PERIPHERAL NERVOUS SYSTEM; PERTUSSIS TOXIN; RECEPTORS, SIGMA; STEROIDS; VIRULENCE FACTORS, BORDETELLA;

EID: 0034912581     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils
2. CB-64D and CB-184: Ligands with high sigma 2 receptor affinity and subtype selectivity
3. Steroid modulation of the nicotinic acetylcholine receptor
4. Neurosteroids biosynthesis and function of these novel neuromodulators
5. Modulation of ionotropic glutamate receptors by neuroactive steroids
6. Purification, molecular cloning, and expression of the mammalian sigmal-binding site
7. Modulation of the GABA receptor complex by a steroid anaesthetic
8. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: Characterization by ligand binding and photoaffinity labeling
9. Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice
10. Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord
11. Protein kinase C-mediated acute tolerance to peripheral μ-opioid analgesia in the bradykinin-nociception test in mice
12. Regulation of sigma receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol: Further evidence for multiple sigma binding sites
13. Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells
14. Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: A role for PBR in neurosteroidogenesis
15. Progesterone and estrogens in rat brain: Modulation of GABA (gamma-aminobutyric acid) receptor activity
16. Neurosteroid antagonists of the GABAA receptors
17. Characterization of two novel sigma receptor ligands: Antidystonic effects in rats suggest sigma receptor antagonism
18. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist
19. Neuroactive neurosteroids as endogenous effectors for the sigma 1 (σ1) receptor: Pharmacological evidence and therapeutic opportunities
20. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor
21. 3H]noradrenaline release in the rat hippocampus: G-protein dependency
22. The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin
23. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus
24. Intracellular sigma 1 receptor modulates phospholipase C and protein kinase C activities in the brainstem
25. Pregnenolone binds to microtubule-associated protein 2 and stimulates microtubule assembly
26. A proposal for the classification of sigma binding sites
27. Neurosteroids: From definition and biochemistry to physiopathologic function
28. Steroid binding at sigma-"opioid" receptors
29. 3 receptor involved in C-fiber nociception mechanisms
30. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems
31. 2+-ATPase
32. i1
33. In vivo molecular signal transduction of peripheral mechanisms of pain
34. 2+ influx
35. Complete inhibition of purinoceptor agonist-induced nociception by spinorphin, but not by morphine
36. Inositol 1,4,5-trisphosphate-gated calcium transport through plasma membranes in nerve terminals
37. Neurosteroids stimulate G protein-coupled sigma receptors in mouse brain synaptic membrane
38. Localization of type I inositol 1,4,5-triphosphate receptor in the outer segments of mammalian cones
39. Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding
40. i1 by lysophosphatidic acid receptor without ligand in the baculovirus expression system
41. Ethical guidelines for investigations of experimental pain in conscious animals